Aphidicolin decreases ex vivo resistance to cytosine arabinoside in childhood acute leukaemia.

Oncology reports

Volumn 10, Issue 6, 2003, Pages 2027-2031

  Sargent, Jean M ^a   Williamson, Christine J ^a   Hubeek, Isabelle ^a   Elgie, Alena W ^a   Taylor, Colin G ^a   Den Boer, Monique L ^a   Peters, Godefridus J ^a   Kaspers, Gertjan L ^a  

^a Pembury Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN; CYTARABINE; DNA DIRECTED DNA POLYMERASE; ENZYME INHIBITOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CELL SURVIVAL; CHILD; CLINICAL TRIAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG RESISTANCE; FEMALE; HUMAN; INFANT; MALE; PRESCHOOL CHILD; TIME;

APHIDICOLIN; CELL SURVIVAL; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; CYTARABINE; DNA-DIRECTED DNA POLYMERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; ENZYME INHIBITORS; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; TIME FACTORS;

MLCS; MLOWN;

EID: 2642547615     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.10.6.2027     Document Type: Article

References (0)